Skip to main content
Caplight Logo









AdipoPharma

AdipoPharma

Private
StrasbourgHealthcare & Life Scienceshttps://adipopharma.com/

Last Round

Series A

Jan 23, 2023

Momentum

Top 25%

of companies Caplight tracks

Company Overview

AdipoPharma is a biotechnology company that develops peptide-based therapeutic treatments for insulin resistance and Type 2 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologytherapeutic peptideinsulin resistancetype 2 diabetesmetabolic diseasedrug discoveryclinical trialsadipocyte dysfunctionbiotech startupmetabolic healthdrug developmentlipid homeostasispharma pipelineclinical-stage biotechmacrocyclic peptide

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AdipoPharma Comparables

Compare AdipoPharma with similar companies based on industry and business-model similarity.

AdipoPharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Adipo Therapeutics
81%
Antag Therapeutics
81%
KeyBioscience AG
77%

AdipoPharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 23, 2023

Key People

Founding team and executive leadership

Vincent Marion

President & CEO

Executive Team

Catherine Pérot

Chief Financial Officer

Executive Team

Michael Fare

Chief Operating Officer

Executive Team

AdipoPharma Investors

Notable investors and investment history

AdipoPharma investors
InvestorRounds
Good Growth CapitalSeries A
OkeanosSeries A
ORSASeries A
SambrinvestSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors grew 474% MoM, from 399 to 2.3K.

  • Apr 6, 2026

    Monthly visitors increased 67% MoM.

AdipoPharma Filings

Explore SEC and related filing metadata, where available.

AdipoPharma filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about AdipoPharma's valuation, stock price, and market status.

Is AdipoPharma a public or private company?

AdipoPharma is a private company.

What is the current stock price of AdipoPharma?

AdipoPharma is a private company with no public stock price. No recent secondary market data is available.

How much is AdipoPharma worth (valuation)?

Valuation information for AdipoPharma is not publicly available.

Can I buy AdipoPharma stock?

AdipoPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was AdipoPharma's last funding round?

AdipoPharma's most recent funding round was Series A on January 23, 2023.

Who are the main investors in AdipoPharma?

Key investors in AdipoPharma include Good Growth Capital, Okeanos, ORSA, Sambrinvest.

Will AdipoPharma IPO soon?

No public IPO plans have been announced for AdipoPharma.

How can I track AdipoPharma secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor AdipoPharma's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersStrasbourg
Employee Range7
Year Founded2022
Last FundingJan 23, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?